About BiLab

About BiLab2020-09-30T16:31:02+00:00
Overview

BiLab revolutionizes cardiopulmonary monitoring with its state-of-the-art technology of electrical impedance tomography (EIT). Noninvasive continuous monitoring of tidal volume and stroke volume is now possible through cross-sectional EIT imaging of the chest.

BiLab’s innovative EIT technology can enhance patient safety and recovery at reduced costs.  Providing pathbreaking solutions to cardiopulmonary monitoring, BiLab supports clinical research to improve patient outcomes using this revolutionary image-based monitoring technology.

History

2020

  • Series B funding from a strategic investor
  • Development of AirTom-PV100
  • Development of HemoVista100
  • Clinical studies

2019

  • GMP certification from the MFDS in Korea
  • AirTom-R approval from the MFDS in Korea
  • Series A funding from a strategic investor
  • Completion of AirTom-RM100

2018

  • Product design and sample production
  • Animal studies and volunteer studies
  • GMP and medical device approval processes

2017

  • Seed funding from Innopolis Partners
  • Patents transfer from Kyung Hee University
  • Prototype EIT system development
  • Animal studies and clinical studies

2016

  • Founded in July 2016
  • Technology transfer from Impedance Imaging Research Center (IIRC)